Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
01/2004
01/13/2004US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/08/2004WO2004002939A2 Aminoalcohol derivatives
01/08/2004WO2003072246A3 Supported silver catalyst and an epoxidation process using the catalyst
01/08/2004US20040006238 As chemical intermediates for production of pharmacologically useful oxazolidinones
01/08/2004US20040006143 Aminoalcohol derivatives
01/08/2004CA2492065A1 Aminoalcohol derivatives_as b3 adrenergic receptor agonist
01/07/2004CN1466567A Substituted 1-aminobutan-3-01 derivatives
01/07/2004CN1133618C Method for prodn. of amino ethyl-hydramine and/or ethylol piperazine
01/06/2004US6673838 Succinate salt of O-desmethyl-venlafaxine
01/06/2004US6673794 Substituted aminomethyl-phenyl-cyclohexane derivatives
01/06/2004US6673122 Compositions for dyeing keratin fibers containing para-aminophenols, dyeing process, novel para-aminophenols and process for their preparation
01/02/2004EP1375471A1 Bis-o-amino(thio)phenols and their preparation
01/02/2004EP1372632A1 Proliferative activator receptor (ppar) compounds
01/01/2004US20040002549 Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them
01/01/2004US20040000471 Storage stability; discoloration inhibition; mixing with ethyleneamine; distillation
12/2003
12/31/2003WO2004000786A1 Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
12/31/2003WO2004000783A1 Aminoalkylphenols, methods of using and making the same
12/31/2003WO2004000782A1 Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid
12/31/2003WO2003072055A3 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
12/31/2003CN1132811C Prepn of chiral compounds S-(+)-and R-(-)-1-(alpha-aminobenzyl)-2-naphthol
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670344 Having greater solubility than native combretastatin A-4, and rapidly regenerate combretastatin A-4 under physiological conditions; for use in cancer therapy
12/30/2003CA2051399C Therapeutically useful 2-aminotetralin derivatives
12/25/2003US20030236309 Novel formate salt of O-desmethyl-venlafaxine
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
12/25/2003US20030236225 Substituted ethylene diamines for the treatment of infectious diseases; used for mycobacterial infections, including tuberculosis
12/25/2003US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/25/2003US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/24/2003WO2003091292A3 Polymerisation catalyst
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/18/2003WO2003104186A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ß-AMINO ALCOHOL
12/18/2003WO2003104178A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003WO2003103650A1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol
12/18/2003WO2003103609A2 Novel trifluoromethylepinephrine compounds and methods of making and using thereof
12/18/2003WO2003103603A2 Novel formate salt of o-desmethyl-venlafaxine
12/18/2003WO2003055599A8 Catalyst supported on carbon having macroporosity for purification of aromatic acids
12/18/2003WO2002067916A3 Pharmaceutical salts
12/18/2003US20030232891 For therapy of pain
12/18/2003CA2488613A1 Novel formate salt of o-desmethyl-venlafaxine
12/18/2003CA2487866A1 Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (mif)
12/18/2003CA2483141A1 Novel trifluoromethylepinephrine compounds and methods of making and using thereof
12/17/2003EP1370591A2 Active non-metallocene pre-catalyst and method for tactic catalytic polymerization of alpha-olefin monomers
12/17/2003EP1370514A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/16/2003US6664424 Stereoscopically-pure stereoisomer; use relieving nasal, sinus and bronchial congestion and of treating attention deficit hyperactivity disorder and obesity; also use to induce pupil dilation
12/16/2003US6664361 Aromatic polycarbonates; electrography
12/11/2003WO2003101937A1 Synthetic methods for the large scale production from glucose of analogs of sphingosine, azidosphingosine, ceramides, lactosyl ceramides, and glycosyl phytosphingosine
12/11/2003WO2003101927A1 Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
12/11/2003WO2003101440A1 Metabolite of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentane-3-ol and the use thereof in the treatment of urinary incontinence
12/11/2003WO2003045909A3 Methods and intermediates for the synthesis of azepines
12/11/2003US20030229251 Production of 2-amino-2-[2- (4-alkylphenyl) ethyl] propane-1, 3-diols
12/11/2003US20030229148 2-aminotetralines, a process for their preparation, and pharmaceutical compositions, for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229058 Aryl aniline beta2 adrenergic receptor agonists
12/10/2003EP1368299A2 Substituted c-cyclohexylmethylamine derivatives
12/10/2003EP1083889B1 Tetrahydronaphtalene compounds and their use for the treatment of neurodegenerative diseases
12/10/2003EP0971885B1 Process for preparing indane-like compounds
12/10/2003CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins
12/10/2003CN1461291A Method for isomerisation of alcohols
12/09/2003US6660742 Alkylation therapy; anticancer agent
12/04/2003WO2003099776A1 Calcium receptor modulating arylalkylamines
12/04/2003WO2003099769A1 Anilino liver x-receptor modulators
12/04/2003WO2003099192A2 Bis-aromatic alkanols
12/04/2003US20030225292 Clean, high-yield preparation of S,S and R,S amino acid isosteres
12/04/2003US20030225285 Oxidizing a protected aminoalcohol to a chiral protected aminoaldehyde and diastereoselectively forming the aminoepoxide from said aminoaldehyde with an organometallic methylene-adding reagent in an appropriate solvent
12/04/2003US20030225164 Carbocyclic amines such as 4-(3-(4-Phenylcyclohexylamino)-propyl)phenol, administered as N-Methyl-D-Aspartate (NMDA) receptor inhibitors, for prophylaxis of cardiovascular, brain or nervous system disorders
12/04/2003US20030225130 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/04/2003CA2486644A1 Anilino liver x-receptor modulators
12/03/2003EP1367046A1 Disubstituted lavendustin A analogs and pharmaceutical compositions comprising the analogs
12/03/2003EP1366015A1 Benzene-1 2-diol mannich bases ligands polymers and method of selective metal ions removal
12/02/2003US6657093 Preparation of substituted aromatic compounds
12/02/2003US6657070 Production of chirally pure α-amino acids and N-sulfonyl α-amino acids
12/02/2003CA2136102C Process for producing n,n-disubstituted aminophenol
11/2003
11/27/2003WO2003096989A2 Anti tubercular drug: compositions and methods
11/27/2003WO2003096987A2 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/27/2003WO2003053370A3 Novel developer components
11/27/2003US20030220390 Carbocyclic oxy amines such as 2-benzylidene-6-dimethylamino methylcyclohexanone, used as analgesics
11/27/2003US20030220389 Tertiary amines such as 2-dimethylaminomethyl-1-(3-methoxy-phenyl)-6-methylcyclohexanol, used as analgesics
11/27/2003CA2485592A1 Anti tubercular drug: compositions and methods
11/27/2003CA2485586A1 Methods of use and compositions for the diagnosis and treatment of infectious disease
11/26/2003EP1363587A1 Novel coupler for use in oxidative hair dyeing
11/26/2003CN1458921A Process for making N-aryl-anthranilic acid and their derivatives
11/25/2003US6653508 Use treating various medical conditions, including pain
11/25/2003US6653326 Hydroxylamine derivatives useful for enhancing the molecular chaperon production and the preparation thereof
11/25/2003US6653323 Aryl aniline β2 adrenergic receptor agonists
11/20/2003WO2003095585A1 Heat exchange fluids
11/20/2003WO2003066572B1 Polyamine compounds and compositions for use in conjunction with cancer therapy
11/20/2003WO2003050062A3 PRODUCTION OF CHIRALLY PURE α-AMINO ACIDS ADN N-SULFONYL α-AMINO ACIDS
11/20/2003WO2003042134A3 Process for the preparation of tertiary amines from primary amines and nitriles
11/20/2003WO2003008559A3 Novel analogs of choline for neuroprotection and cognitive enhancement in neurodegenerative disorders
11/20/2003WO2002002506A8 Compounds to treat alzheimer's disease
11/20/2003WO2002002505A8 Compounds to treat alzheimer's disease
11/20/2003US20030216572 Process to produce oxazolidinones
11/20/2003US20030216393 Administering to a patient in need an effective pain treating amount of a substituted 1-aminobutan-3-ol compound to treat migraines, hyperalgesia, inflammatory pain, and post-operative pain
11/20/2003US20030215801 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/20/2003US20030215734 Such as 2,2'-methylenebis(4-methyl-6-hydroxymethylphenol) for production of photosensitive polyimides
11/19/2003EP1361874A1 Treatment of diseases characterized by excessive or insufficient cell death
11/19/2003EP1361851A1 Primary intermediates for oxidative coloration of hair
11/19/2003EP1017667B1 2-Amino-6-methyl-7-acetyl-tetraline and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
1 ... 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 ... 116